The acquisition combines blood-based biomarker tests with retinal imaging and telehealth to support early detection of Alzheimer’s and Parkinson’s diseases.
NeuroVision Imaging Inc announced the acquisition of Durin Life Sciences Inc to create an integrated diagnostics and care platform for neurodegenerative diseases. The deal aims to improve early detection, patient access, and long-term brain health management, according to a company release.
The transaction combines the blood-based biomarker diagnostics platform from Durin with the retinal imaging technology, telehealth infrastructure, and patient engagement platform from NeuroVision. The combined company will operate under the NeuroVision name and will be led by Steven Verdooner, CEO and co-founder of NeuroVision.
The companies intend to accelerate the development and commercialization of diagnostic solutions for Alzheimer’s disease, Parkinson’s disease,, amyotrophic lateral sclerosis, and related neurological disorders. This will be achieved by pairing biomarker science with clinical, data, and patient engagement capabilities, according to the release.
Durin Life Sciences developed Duritect, a suite of blood-based diagnostic tests designed to support the early detection and monitoring of neurodegenerative disease. NeuroVision provides the BrainHealth.net platform, which supports patients, providers, and healthcare organizations across the US through telehealth-enabled cognitive assessment, care navigation, and longitudinal brain health programs.
“We’ve long believed that the future of neurodegenerative disease care begins with earlier and more accessible detection,” says Verdooner, CEO and co-founder of NeuroVision, in a release. “Durin’s blood-based biomarker platform represents an important advancement in that direction. By bringing together complementary strengths in diagnostics, technology, and patient engagement, we believe we are uniquely positioned to help advance brain health at scale while supporting patients and families throughout the care journey.”
Ric Edelman, majority owner of Durin, is joining the board of the combined enterprise.
“This is a milestone for Durin and for everyone who has been part of our journey, and we’re excited to be joining forces with NeuroVision,” says Edelman, majority owner of Durin, in a release.
ID 183506792 © Ilia Burdun | Dreamstime.com
